Perrigo hails reform of US monographs
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Efforts by the US Food and Drug Administration (FDA) to modernise the country’s OTC monograph system will present opportunities for Perrigo to grow its Consumer Healthcare Americas business, according to the firm’s chief financial officer Ron Winowiecki.